Cargando…
Safety and in vivo Expression of a GNE-Transgene: A Novel Treatment Approach for Hereditary Inclusion Body Myopathy-2
Hereditary inclusion body myopathy-2 (HIBM2) is an adult-onset, muscular disease caused by mutations in the GNE gene. HIBM2-associated GNE mutations causing hyposialyation have been proposed to contribute to reduced muscle function in patients with HIBM2, though the exact cause of this disease is un...
Autores principales: | Phadke, Anagha P., Jay, Chris, Chen, Salina J., Haddock, Courtney, Wang, Zhaohui, Yu, Yang, Nemunaitis, Derek, Nemunaitis, Gregory, Templeton, Nancy S., Senzer, Neil, Maples, Phillip B., Tong, Alex W., Nemunaitis, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758285/ https://www.ncbi.nlm.nih.gov/pubmed/19838336 |
Ejemplares similares
-
Preclinical Assessment of wt GNE Gene Plasmid for Management of Hereditary Inclusion Body Myopathy 2 (HIBM2)
por: Jay, Chris, et al.
Publicado: (2008) -
Hereditary Inclusion Body Myopathy (HIBM2)
por: Jay, Chris M., et al.
Publicado: (2009) -
Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease
por: Simmons, Olivia, et al.
Publicado: (2012) -
Emerging technologies for the genomic analysis of cancer
por: Nemunaitis, John, et al.
Publicado: (2009) -
Letter to the editor: Does Dicer Expression Affect shRNA processing?
por: Senzer, Neil, et al.
Publicado: (2009)